Reid JM - Search Results

1

Randomized Phase III Trial of Ganitumab With Interval-Compressed Chemotherapy for Patients With Newly Diagnosed Metastatic Ewing Sarcoma: A Report From the Children's Oncology Group.

DuBois SG, Krailo MD, Glade-Bender J, Buxton A, Laack N, Randall RL, Chen HX, Seibel NL, Boron M, Terezakis S, Hill-Kayser C, Hayes A, Reid JM, Teot L, Rakheja D, Womer R, Arndt C, Lessnick SL, Crompton BD, Kolb EA, Daldrup-Link H, Eutsler E, Reed DR, Janeway KA, Gorlick RG. DuBois SG, et al. Among authors: reid jm. J Clin Oncol. 2023 Apr 10;41(11):2098-2107. doi: 10.1200/JCO.22.01815. Epub 2023 Jan 20. J Clin Oncol. 2023. PMID: 36669140 Free PMC article. Clinical Trial.

2

Plasma pharmacokinetics and cerebrospinal fluid concentrations of idarubicin and idarubicinol in pediatric leukemia patients: a Childrens Cancer Study Group report.

Reid JM, Pendergrass TW, Krailo MD, Hammond GD, Ames MM. Reid JM, et al. Cancer Res. 1990 Oct 15;50(20):6525-8. Cancer Res. 1990. PMID: 2208112 Clinical Trial.

3

Phase I study of temozolomide in children and adolescents with recurrent solid tumors: a report from the Children's Cancer Group.

Nicholson HS, Krailo M, Ames MM, Seibel NL, Reid JM, Liu-Mares W, Vezina LG, Ettinger AG, Reaman GH. Nicholson HS, et al. Among authors: reid jm. J Clin Oncol. 1998 Sep;16(9):3037-43. doi: 10.1200/JCO.1998.16.9.3037. J Clin Oncol. 1998. PMID: 9738573 Clinical Trial.

4

Phase I study of topotecan administered as a 21-day continous infusion in children with recurrent solid tumors: a report from the Children's Cancer Group.

Frangoul H, Ames MM, Mosher RB, Reid JM, Krailo MD, Seibel NL, Shaw DW, Steinherz PG, Whitlock JA, Holcenberg JS. Frangoul H, et al. Among authors: reid jm. Clin Cancer Res. 1999 Dec;5(12):3956-62. Clin Cancer Res. 1999. PMID: 10632325 Clinical Trial.

5

A phase I clinical, pharmacological, and biological trial of interleukin 6 plus granulocyte-colony stimulating factor after ifosfamide, carboplatin, and etoposide in children with recurrent/refractory solid tumors: enhanced hematological responses but a high incidence of grade III/IV constitutional toxicities.

Bracho F, Krailo MD, Shen V, Bergeron S, Davenport V, Liu-Mares W, Blazar BR, Panoskaltsis-Mortari A, van de Ven C, Secola R, Ames MM, Reid JM, Reaman GH, Cairo MS. Bracho F, et al. Among authors: reid jm. Clin Cancer Res. 2001 Jan;7(1):58-67. Clin Cancer Res. 2001. PMID: 11205919 Clinical Trial.

6

Phase I trial of cisplatin and topotecan in children with recurrent solid tumors: Children's Cancer Group Study 0942.

Wells RJ, Reid JM, Ames MM, Mares WL, Krailo MD, Seibel NL, Mosher R, Reaman GH, Wiersma SR. Wells RJ, et al. Among authors: reid jm. J Pediatr Hematol Oncol. 2002 Feb;24(2):89-93. doi: 10.1097/00043426-200202000-00006. J Pediatr Hematol Oncol. 2002. PMID: 11990712 Clinical Trial.

7

Phase I study of gemcitabine (difluorodeoxycytidine) in children with relapsed or refractory leukemia (CCG-0955): a report from the Children's Cancer Group.

Steinherz PG, Seibel NL, Ames MM, Avramis VI, Krailo MD, Liu-Mares W, Reid JM, Safgren SL, Reaman GH. Steinherz PG, et al. Among authors: reid jm. Leuk Lymphoma. 2002 Oct;43(10):1945-50. doi: 10.1080/1042819021000015880. Leuk Lymphoma. 2002. PMID: 12481889 Clinical Trial.

8

Phase I trial and pharmacokinetics of gemcitabine in children with advanced solid tumors.

Reid JM, Qu W, Safgren SL, Ames MM, Krailo MD, Seibel NL, Kuttesch J, Holcenberg J. Reid JM, et al. J Clin Oncol. 2004 Jun 15;22(12):2445-51. doi: 10.1200/JCO.2004.10.142. J Clin Oncol. 2004. PMID: 15197207 Clinical Trial.

9

Phase I clinical and pharmacokinetic study of flavopiridol in children with refractory solid tumors: a Children's Oncology Group Study.

Whitlock JA, Krailo M, Reid JM, Ruben SL, Ames MM, Owen W, Reaman G; Children's Oncology Group Study. Whitlock JA, et al. Among authors: reid jm. J Clin Oncol. 2005 Dec 20;23(36):9179-86. doi: 10.1200/JCO.2004.01.0660. J Clin Oncol. 2005. PMID: 16361620 Clinical Trial.

10

Phase I trial of oral fenretinide in children with high-risk solid tumors: a report from the Children's Oncology Group (CCG 09709).

Children's Oncology Group (CCG 09709); Villablanca JG, Krailo MD, Ames MM, Reid JM, Reaman GH, Reynolds CP. Children's Oncology Group (CCG 09709), et al. Among authors: reid jm. J Clin Oncol. 2006 Jul 20;24(21):3423-30. doi: 10.1200/JCO.2005.03.9271. J Clin Oncol. 2006. PMID: 16849757 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

503 results

Search Page